𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LRRK2mutation in familial Parkinson’s disease in a Taiwanese population: clinical, PET, and functional studies

✍ Scribed by Chin-Hsien Lin; Kai-Yuan Tzen; Chin-Yi Yu; Chun-Hwei Tai; Matthew J. Farrer; Ruey-Meei Wu

Publisher
BioMed Central
Year
2008
Tongue
English
Weight
272 KB
Volume
15
Category
Article
ISSN
1021-7770

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

G2019S LRRK2 mutation in familial and sp
G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia
✍ Sofya N. Pchelina; Andrei F. Yakimovskii; Olga N. Ivanova; Anton K. Emelianov; A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract Among mutations associated with autosomal dominant and sporadic Parkinson's disease (PD) the G2019S substitution in the leucine‐rich repeat kinase 2 (LRRK2) gene is the most frequently identified. To estimate its frequency in Russia, we analyzed 208 patients with PD from the Northwester

Lack of G2019S LRRK2 mutation in a cohor
Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease
✍ Hon-Chung Fung; Chiung-Mei Chen; John Hardy; Dena Hernandez; Andrew Singleton; Y 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

## Abstract Mutations in the leucine‐rich repeat kinase 2 (__LRRK2__) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycine‐to‐serine amino acid substitution at cod

High prevalence of LRRK2 mutations in fa
High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal
✍ Joaquim J. Ferreira; Leonor Correia Guedes; Mário Miguel Rosa; Miguel Coelho; Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Mutations in the __Leucine‐Rich Repeat Kinase 2__ (__LRRK2__) gene are the most frequent known cause of Parkinson's disease (PD), but their prevalence varies markedly between populations. Here we studied the frequency and associated phenotype of four recurrent __LRRK2__ mutations (R1441

Parkinson's disease and LRRK2: Frequency
Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics
✍ Denise M. Kay; Cyrus P. Zabetian; Stewart A. Factor; John G. Nutt; Ali Samii; Al 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

## Abstract The G2019S mutation in the __LRRK2__ gene is reportedly a common cause of familial Parkinson's disease (PD) and may also have a significant role in nonfamilial PD. The objective of this study was to assess mutation carrier frequency in PD patients from movement disorder clinics in the U

Prevalence and clinical features of comm
Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease
✍ Yue Huang; Glenda M. Halliday; Himesha Vandebona; George D. Mellick; Frank Masta 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract We determined the prevalence of two common leucine‐rich repeat kinase 2 (LRRK2) gene mutations in Australian patients with Parkinson's disease (PD). Of 830 affected patients, eight were heterozygous for the G2019S mutation, and two were heterozygous for the R1441H (4,322 G > A) mutation